Chenxi Wu
Publications by Year
Research Areas
Hippo pathway signaling and YAP/TAZ, Nanoplatforms for cancer theranostics, RNA modifications and cancer, Cancer-related molecular mechanisms research, Immunotherapy and Immune Responses
Most-Cited Works
- → Visualization of Protease Activity In Vivo Using an Activatable Photo-Acoustic Imaging Probe Based on CuS Nanoparticles(2014)145 cited
- → An optimized ionizable cationic lipid for brain tumor-targeted siRNA delivery and glioblastoma immunotherapy(2022)114 cited
- → Studies on the antioxidant and hepatoprotective activities of polysaccharides from Talinum triangulare(2011)112 cited
- → Histone deacetylase inhibitors are neuroprotective and preserve NGF-mediated cell survival following traumatic brain injury(2013)88 cited
- → Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 + T cells(2020)84 cited
- → Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib(2020)81 cited
- → Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson’s disease(2023)79 cited
- → Toll pathway modulates TNF-induced JNK-dependent cell death inDrosophila(2015)70 cited
- → Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression(2014)67 cited
- → ALKBH5/YTHDF2‐mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation(2023)65 cited